Invention Grant
- Patent Title: Minimal volume reprogramming of mononuclear cells
-
Application No.: US14731403Application Date: 2015-06-04
-
Publication No.: US10023879B2Publication Date: 2018-07-17
- Inventor: Peter Flynn , Bahram Valamehr
- Applicant: FATE THERAPEUTICS, INC.
- Applicant Address: US CA San Diego
- Assignee: Fate Therapeutics, Inc.
- Current Assignee: Fate Therapeutics, Inc.
- Current Assignee Address: US CA San Diego
- Agency: Jones Day
- Main IPC: C12N5/00
- IPC: C12N5/00 ; C12N15/85 ; A61K35/545 ; A61K35/51 ; A61K35/12
Abstract:
The invention provides compositions and methods for reprogramming minimal volumes of mononuclear cells. In particular aspects, the invention provides methods and compositions for reprogramming minimal volumes of umbilical cord blood obtained from cord blood segments from cryopreserved cord blood segments.
Public/Granted literature
- US20150376646A1 MINIMAL VOLUME REPROGRAMMING OF MONONUCLEAR CELLS Public/Granted day:2015-12-31
Information query
